CRWV market-structure snapshot

$CRWV: multi-source stock research

CoreWeave, Inc.

MARKET STRUCTURE

Latest close on July 31, 2026: $72.35 (-2.1% on the latest daily bar).

HMA21 / HMA55: $68.18 / $68.99. 200DMA: $94.83.

Relative volume: 0.82x the 20-day average.

Nearest support/watch zone: $69.97.

Nearest resistance/watch zone: $78.50.

Price is below the 200DMA, so the long-term trend reference is still defensive.

FUNDAMENTALS AND VALUATION

Latest comparable filing period: 2026 Q1 ending 2026-03-31; filed 2026-05-08.

Comparable growth: revenue +111.6% YoY; net income +134.9% YoY; diluted EPS -6.0% YoY.

Quality and cash conversion: net margin -35.6% (-353 bp YoY); quarterly SEC free-cash-flow proxy -$4.71B (-250.0% YoY).

Valuation snapshot: EV/EBITDA 24.2x; P/S 6.3x.

Read-through:
• Net income grew faster than revenue, indicating positive earnings leverage in the comparable period.
• Diluted EPS growth lagged net-income growth, making share-count effects worth monitoring.
• Cash generation weakened versus the comparable period.

RECENT INSTITUTIONAL RESEARCH

• 2026-07-09 — CoreWeave 2Q26 Preview: A Hold (Bernstein)

Bernstein described AI cloud company CoreWeave (CRWV.US)’s second quarter of 2026 as “a quarter to sit through”—a lackluster transitional quarter. The company’s guidance calls for adjusted operating income (AOI) of just $30 million to $90 million in 2Q26, compared with full-year 2026 revenue guidance of approximately $12 billion to $13 billion.

The rationale is that CoreWeave is in a phase of aggressively ramping up data-center infrastructure, deploying GPUs, and incurring substantial capital expenditures before fully monetizing that capacity.

BOTTOM LINE

The technical structure is mixed, while the latest comparable period showed growth in both revenue and net income. The next confirmation must come from both price structure and the next reported operating data—not from narrative alone.

WHAT TO WATCH

• Holding above HMA21 near $68.18 would preserve the short-term structure.
• A close below the nearby support zone around $69.97 would weaken the setup.
• Whether the next filing confirms that revenue growth is converting into net income, EPS and cash flow.
• Whether the operating milestones identified in recent institutional research become measurable disclosures.

#Stocks #Fundamentals #TechnicalAnalysis #CRWV